Pearl IRB has a Full Board meeting scheduled for December 16. There will be no meetings on December 23 or 30. The regularly scheduled Full Board meetings will resume on January 6, 2016. If you have an urgent IRB concern, please contact us at least two weeks in...
In a recent article on Outsourcing Pharma, Dan Stanton discusses the new EU clinical trial regulation and it’s intention to simplify the approval process in hopes of making the EU more accessible and desirable for clinical research. The new regulation will take action...
Pearl Pathways announces the addition of a second location in College Station, Texas. Through the support of the Research Valley Partnership and its Research Valley Innovation Center, Pearl Pathways has the unique opportunity of expanding into a new market. Diana...
The Government Accountability Office (GAO) recently released a report in regard to women in clinical research. While past efforts by the National Institutes of Health (NIH) have increased the number of women involved in research, further changes are still necessary....
Wearable technology has been taking over the consumer world for health and fitness, and speculation has grown around the topic of utilizing the devices in clinical trials. First Post Business addressed the idea, along with input from Michael Shanler, research director...
